KLF4 and chronic myelogenous leukemia, BCR-ABL1 positive: Because KLF4 expression is required to sustain CML disease through the regulation of LSC self-renewal, the identification of KLF4-regulated genes in CML LSCs has the potential to uncover new targets for CML therapy.